Alamo Group Inc. — Form 10-Q Summary
Reporting period: Quarter and nine months ended September 30, 2013. The unaudited results cover Alamo Group Inc. and its subsidiaries, which manufacture and sell equipment across North American Industrial, North American Agricultural, and European segments.
Financial performance
| Metric | Q3 2013 | Q3 2012 | Nine months 2013 | Nine months 2012 |
|---|---|---|---|---|
| Net sales | $174.7m | $156.1m | $511.2m | $479.0m |
| Gross profit | $43.2m | $37.1m | $122.2m | $111.5m |
| Gross margin | 24.7% | 23.8% | 23.9% | 23.3% |
| Operating income | $15.3m | $13.1m | $42.6m | $38.4m |
| Net income | $11.3m | $8.6m | $30.1m | $24.7m |
| Diluted EPS | $0.93 | $0.71 | $2.47 | $2.05 |
Q3 sales rose 12.0% year over year and nine-month sales rose 6.7%. Nine-month net income increased 21.7%. Higher sales volume and production efficiencies supported improved gross margins; SG&A increased to $27.8m in Q3 and $79.5m for the nine months, partly due to litigation matters, commissions, incentive compensation, French operations, and stock-based compensation.
Sales by segment
- Q3: Industrial $71.9m, up 16.0%; Agricultural $61.2m, up 13.0%; European $41.7m, up 4.3%.
- Nine months: Industrial $218.9m, up 11.2%; Agricultural $168.0m, up 8.1%; European $124.3m, down 1.9%.
- Nine-month segment operating income was $20.0m Industrial, $16.3m Agricultural, and $6.3m European, compared with $15.0m, $14.5m, and $8.9m, respectively, in 2012.
Cash flow, balance sheet, and liquidity
- Nine-month operating cash flow was $17.0m, down from $27.5m in 2012. Cash use included increases in receivables ($20.9m) and inventories ($11.8m), partly offset by higher payables and accrued liabilities.
- Investing cash outflow was $10.5m, including $9.9m of capital expenditures and $1.0m for acquisitions. Capital spending was up from $3.5m in 2012, primarily reflecting plant expansions in the U.K. and Canada.
- Cash increased to $53.6m from $48.3m at December 31, 2012. Working capital was $253.4m, up $24.7m.
- At September 30, total debt and capital lease obligations were approximately $0.6m, including current maturities; the company reported no borrowings under its $100m revolving facility and $99.3m of available capacity after letters of credit. It also had €0.7m outstanding on its French line of credit. The company reported compliance with credit covenants.
- $39.7m of cash was held by foreign subsidiaries and, according to the filing, generally was not available for U.S. use without tax consequences. Management expects operating cash flow and credit facilities to meet foreseeable cash needs.
- Dividends declared were $0.07 per share in Q3 and $0.21 per share for the first nine months.
Changes, outlook, and risks
- Management described 2013 markets as expected to be steady and said backlog had improved year over year, which it expected to benefit sales through the rest of the year. No specific quantitative earnings or revenue guidance was provided.
- North American demand strengthened, while European sales remained affected by economic weakness; Q3 European sales increased for the first time in several years. Management noted signs of improvement but continued uncertainty.
- Q3 other income included a $0.475m U.K. government grant. Nine-month other income also included a $0.070m gain on sale of a Memphis warehouse and foreign-exchange effects. The nine-month tax provision benefited from a $0.350m R&D credit recognized in 2013, as well as other tax credits and benefits.
- Foreign-currency exposure is material: management estimated that a uniform 10% strengthening of the U.S. dollar would reduce nine-month gross profit by approximately $4.2m. The company reported forward exchange contracts of $4.7m related to receivables.
- Risks cited include economic and credit-market weakness, government budgets and regulation, agricultural commodity prices and weather, raw-material and energy costs, competition, litigation, and customer demand. Goodwill was $31.8m; the Schwarze and Rivard reporting units had carrying values not materially different from estimated fair values, creating potential exposure to future impairment if assumptions deteriorate.
- Contingencies include environmental monitoring and remediation matters and possible asbestos remediation. The filing states that the company believes any asbestos liability change would not materially affect its financial position or results; it also describes ongoing monitoring at certain sites.
Most important facts for investors to verify
- Whether backlog and North American demand translated into sustained sales and margins after September 30, particularly given management’s “steady” market outlook.
- Whether receivables and inventory growth, and the decline in operating cash flow, reversed or persisted in subsequent periods.
- Whether European operations improved and whether Schwarze or Rivard goodwill assumptions or impairment risk changed.
- The recurring versus one-time contribution of the U.K. grant, tax benefits, and other income to reported earnings.
- Developments in litigation, environmental matters, foreign-exchange exposure, and credit-facility availability.